You’ve been diagnosed with non-muscle-invasive bladder cancer. Your urologist recommends BCG therapy. Then you find out there’s a wait.
For many Canadians, access to BCG immunotherapy through the public system isn’t immediate – and for a treatment where timing matters, that delay creates a problem. Private access to BCG therapy at RCM Health is how some patients choose to address it.
RCM Health’s BCG treatment service offers scheduled, reliable access to intravesical BCG immunotherapy, administered by an experienced urology team in a private clinical setting.
What Is BCG Therapy?
BCG – Bacillus Calmette-Guérin – is a biological immunotherapy that has been used to treat non-muscle-invasive bladder cancer – also called superficial bladder cancer – for decades. It is one of the most well-established treatments in urological oncology, with a long record of reducing recurrence and delaying disease progression.
BCG works by stimulating the immune system to recognize and attack cancer cells in the bladder lining. For appropriately selected patients, BCG is used after surgical removal of the tumour (TURBT) to reduce the risk of recurrence and delay disease progression – helping many patients preserve their bladder and avoid more invasive surgery. It is delivered directly into the bladder through a catheter – a procedure called intravesical instillation – rather than through the bloodstream, which limits systemic side effects.
It is not a new or experimental treatment. It is a standard of care that some patients struggle to access on a predictable schedule.
Who Administers BCG Therapy?
BCG is not a treatment that can be self-administered or delegated to a general practitioner. Intravesical BCG instillation must be performed by or under the direct supervision of a qualified urologist.
At RCM Health, BCG therapy is administered by an experienced urology team in a fully equipped private clinical setting. Our physicians have the specialized training required for this procedure, and our team manages the full treatment protocol – from intake assessment through the induction course and into maintenance scheduling.
If you’ve received a BCG recommendation from your oncologist or urologist and want to understand your options, RCM Health’s health advocacy and consulting service can help you navigate next steps.
Why Patients Choose Private BCG Access
The public health system does provide BCG therapy. For some patients, scheduling is straightforward. For others – depending on geography, institutional capacity, and demand – wait times for treatment initiation or continuation can extend further than is clinically comfortable.
BCG therapy follows a structured protocol: a six-week induction course of weekly in-clinic bladder infusions, followed by a maintenance schedule. Missing or delaying sessions within that protocol has clinical consequences – it isn’t something that can be easily made up later.
Private access at RCM Health means:
- Treatment begins when your oncologist or urologist recommends it begin – not when a public waitlist opens
- Appointments are scheduled consistently, protecting the integrity of your treatment protocol
- You have direct access to your clinical team throughout the process
RCM Health has served Canadian patients since 1993. Our approach to private cancer care is the same as our approach to health advocacy more broadly: independent, expert, and focused on your timeline.
The BCG Treatment Process at RCM Health
Step 1: Intake Assessment Before treatment begins, RCM Health conducts a thorough intake assessment to confirm your diagnosis, review your pathology and imaging, and establish that BCG therapy is appropriate for your specific case. Suitability for BCG is determined at this stage.
Step 2: Treatment Planning Your urology team establishes your treatment schedule – induction course, dosing, and maintenance plan – in coordination with your referring oncologist or urologist where applicable.
Step 3: Weekly Infusions BCG infusions are performed in-clinic on your scheduled day. The procedure typically takes under an hour. You are monitored afterward before discharge.
Step 4: Ongoing Monitoring Your team tracks your response throughout the induction course and adjusts the maintenance schedule based on clinical findings. Follow-up cystoscopy and monitoring align with your overall oncology care plan.
For patients managing complex care coordination across providers, RCM Health’s medical second opinion service is available to ensure your treatment plan is fully reviewed before you begin.
Is BCG therapy covered by OHIP if I access it privately?
The private administration of BCG therapy is not covered by OHIP. RCM Health's BCG service is offered on a private, self-pay basis. We are happy to discuss costs and what is involved during your intake consultation.
Do I need a referral to access BCG treatment at RCM Health?
A referral is not required to contact RCM Health or to request an intake assessment. However, a confirmed diagnosis and pathology report are necessary before treatment can begin. Most patients come to us with documentation from their urologist or oncologist already in hand.
Can I continue BCG treatment at RCM Health if I started in the public system?
Yes. If your public system treatment has been interrupted or delayed, RCM Health can assess your current protocol and continue treatment where appropriate.
What are the side effects of BCG therapy?
BCG therapy is generally well-tolerated. Common side effects include urinary frequency, mild discomfort, and flu-like symptoms following infusions. These are typically short-lived. Your clinical team will review the full side effect profile with you at intake. Decisions about managing side effects, including any supportive medications, are made in consultation with your treating physician.
Is BCG the right treatment for my type of bladder cancer?
BCG is specifically indicated for non-muscle-invasive bladder cancer (also referred to as superficial bladder cancer), particularly high-grade disease. Whether it is the right treatment for your specific diagnosis is a clinical determination made by your urologist or oncologist. If you are unsure or seeking a second perspective, RCM Health's medical second opinion service can provide an independent clinical review.
What To Do Next
- Contact RCM Health to request a BCG intake assessment
- Bring your pathology report and any imaging from your urologist or oncologist
- Review RCM Health’s full cancer care services and health advocacy options
This article is for general information only and is not a substitute for individualized medical advice. BCG therapy suitability is determined at intake in consultation with your treating physician. Individual outcomes vary and are not guaranteed.